Immunogenicity of co-expressed p30-gp90 against Reticuloendotheliosis virus
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

Supported by the Innovative Vaccine Research and Industrialization for Major Animal Epidemics(2011A090200117)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Abstract:[Objective] To study the immunogenicity of co-expression of p30,one of a group specific antigens,and glycoprotein gp90 genes of Reticuloendotheliosis virus (REV).[Methods]p30 and gp90 genes were amplified with the template of plasmid pPB101 containing the whole sequence of spleen necrosis virus(SNV),and cloned into pET-28a(+) vector.The positive clone pET-p30-gp90 was identified by enzyme analysis and sequencing.The co-expressed protein p30-gp90 was confirmed by SDS-PAGE and Western blot analysis. After quantitation,the purified protein p30-gp90 was immunized to Balb/c mice three times to prepare the p30-gp90 specific anti-serum.Afterwards,we detected the REV infected Chick Embryo Fibroblasts (CEF) by Immunofluorescence assay (IFA) with the prepared anti-serum.[Results]The p30-gp90 was co-expressed efficiently by SDS-PAGE and Western blot analysis.The anti-serum of p30-gp90 reacts with REV infected CEF in IFA.[Conclusion]The expressed protein of p30-gp90 keeps good immunogenicity.

    Reference
    Related
    Cited by
Get Citation

Ruiai Chen, Yanpeng Li, Kai Guo, Zhengwei Liu. Immunogenicity of co-expressed p30-gp90 against Reticuloendotheliosis virus. [J]. Acta Microbiologica Sinica, 2014, 54(3): 352-358

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 16,2013
  • Revised:September 14,2013
  • Adopted:
  • Online: March 03,2014
  • Published:
Article QR Code